A few bullish analyst calls to tell you about this morning. 

Yesterday I posted about Verenium’s (VRNM) approval in China for Purifine which sent the stock soaring.  The pull back today is offering a 2nd chance opportunity.  Shares have pulled back to what is now support around the 200 day moving average.

Olympia Capital chimed in on the news and upgraded the stock from Neutral to Buy and raised the price target from $3 to $5.  However, the firm doesn’t see significant revenue from China until next year. 

====> Click Here For Your FREE Daily Verenium Technical Analysis

Rubicon Technology (RBCN), another LED play, is  getting a lift today on news that JP Morgan added the stock to their US Focus List and sees the company beating estimates when it reports Nov 4th.  Shares are up nearly 8% with heavy volume, but is facing some tough resistance around the 50 and 200 day moving averages. 

====> Click Here For Your FREE Daily Rubicon Technical Analysis

JP Morgan also initiated coverage on demand response player Comverge (COMV) with an Overweight rating and $12.50 price target which is about 50% higher than current levels.

====> Click Here For Your FREE Daily Comverge Technical Analysis